Skip to content

Miriam Z Mintzer

4 papers in the library · 193 citations · publishing 2006-2013

Papers

Sort Most recent Most cited

Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.

Drug and Alcohol Dependence March 1, 2013 Lawrence P Carter, Chad J Reissig, Matthew W Johnson et al. 28 citations

Although concerns surrounding high-dose dextromethorphan (DXM) abuse have recently increased, few studies have examined the acute cognitive effects of high doses of DXM. The aim of this study was to compare the cognitive effects of DXM with those of triazolam and placebo. Single, acute, oral doses of DXM (100, 200, 300, 400, 500, 600, 700, 800 mg/70 kg), triazolam (0.25, 0.5mg/70 kg), and...

Cognitive effects of intramuscular ketamine and oral triazolam in healthy volunteers.

Psychopharmacology March 1, 2013 Lawrence P Carter, Bethea A Kleykamp, Roland R. Griffiths et al. 19 citations

Several studies have documented impairments in memory processes as a result of ketamine administration; however, few studies have compared the profile of cognitive effects of ketamine to other drugs. The aim of this study was to compare the cognitive effects of ketamine with those of triazolam in healthy volunteers. Doses of ketamine (0.2, 0.4 mg/kg intramuscular (i.m.)), triazolam (0.2, 0.4...

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.

Psychopharmacology September 1, 2012 Chad J Reissig, Lawrence P Carter, Matthew W Johnson et al. 89 citations

Although reports of dextromethorphan (DXM) abuse have increased recently, few studies have examined the effects of high doses of DXM. This study in humans evaluated the effects of supratherapeutic doses of DXM and triazolam. Single, acute oral doses of DXM (100, 200, 300, 400, 500, 600, 700, and 800 mg/70 kg), triazolam (0.25 and 0.5 mg/70 kg), and placebo were administered to 12 healthy...

Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.

Experimental and Clinical Psychopharmacology November 1, 2006 Michelle R Lofwall, Roland R. Griffiths, Miriam Z Mintzer 57 citations

Ketamine is a noncompetitive N-methyl-D-aspartate (NMDA) antagonist. Given the purported role of the NMDA receptor in long-term potentiation, the primary purpose of the present study was to further understand the dose-related effects of ketamine on memory. The study was also designed to provide information about the relative effects of ketamine on memory versus nonmemory effects and to more...